SMALL CELL CARCINOMA
Clinical trials for SMALL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SMALL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SMALL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising combo cancer study pulled before it began
Disease control TerminatedThis study was designed to test two drugs, tarlatamab and sacituzumab govitecan, in people with advanced small cell lung cancer or a similar neuroendocrine cancer that had stopped responding to prior treatment. The goal was to see if the combination was safe and could shrink tumo…
Matched conditions: SMALL CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 16:01 UTC
-
New hope for rare cancers: immune-boosting drug shows promise
Disease control OngoingThis study tests a drug called pembrolizumab in 157 people with rare tumors that cannot be removed by surgery or have spread. The drug helps the immune system fight cancer by blocking a protein that slows it down. The main goal is to see if the drug can stop tumors from growing f…
Matched conditions: SMALL CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 24, 2026 16:07 UTC